UC Berkeley launched trial of saliva test for COVID-19
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
Altimmune received award from US DoD to fund phase 1/2 clinical trial of T-COVIDﾙ in outpatients with early COVID-19
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
LabCorp introduced Xcellerateﾮ COVID-19 clinical study solution
On Jun. 29, 2020, LabCorpﾮ announced that Covance, its drug development business, has deployed the Xcellerateﾮ COVID-19 solution…
Todos Medical entered into distribution partnership with Meridian Health Services network for COVID-19 testing solutions
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…
U.S. Dept of Veterans Affairs launched COVID-19 screening tool
On Jun. 29, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had launched a digital COVID-19…
Oxford University dashboard highlighted potential future COVID-19 virus hotspots
On Jun. 29, 2020, the University of Oxford reported that potential COVID-19 hotspots can be identified using a…
Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
Association between statewide school closure and COVID-19 incidence and mortality in the US
On Jun. 29, 2020, JAMA reported that U.S. populationﾖbased time series analysis conducted between March 9, 2020, and…
Experts identifed steps to expand and improve antibody tests in COVID-19 response
On Jun. 26, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a…
CIRM board approved third clinical trial for COVID-19
On Jun. 26, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at…
University of Alberta researcher to test whether COVID-19 antibodies provide long-term immunity
On Jun. 25, 2020, the University of Alberta (U of A) announced a study that will analyze thousands…
Entos announced selection of lead candidates for pan-Coronavirus Fusogenix DNA vaccine and $42 million award
On Jun. 25, 2020, Entos Pharmaceuticals announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA…
Government of Canada and provincial partners invested more than $109 mllion in COVID-19 research
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
University of British Columbia received $14 million in federal funding for COVID-19 research
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
Moderna and Catalent announced collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
LabCorp launched new neutralizing antibody test
On Jun. 25, 2020, LabCorpﾮ announced the launch of a new test that can be used to assess…
Texas A&M researchers testing COVID-19 vaccine candidates for iBio
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
RedHill Biopharma announced data from severe COVID-19 patients showed substantial benefit to patients
On Jun. 24, 2020, RedHill Biopharma announced that results from the treatment of the first severe COVID-19 patients…
Why men may fare worse than women against SARS-CoV-2
On Jun. 24, 2020, HHMI investigators reported that data from COVID-19 cases around the world suggest that the…
Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
New Oxford University co-led platform accelerated COVID-19 tests into real-world use
On Jun. 24, 2020, the University of Oxford that the COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR)…
Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
iBio selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, iBio announced that IBM Watson Health has selected iBio to receive 18 months of…
Experts identified steps to expand and improve antibody tests in COVID-19 response
On Jun. 23, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
FibroGen announced first patient enrolled in Pamrevlumab clinical trial in patients hospitalized in US with acute COVID-19
On Jun. 23, 2020, FibroGen announced the initiation of a randomized, double-blind, placebo-controlled Phase 2 Study investigating the…
Mateon selected IQVIA for its randomized, controlled, multi-menter clinical study to test OT-101 as treatment for COVID-19 patients
On Jun. 23, 2020, Mateon Therapeutics announced it had selected IQVIA to manage C001, a Phase 2 randomized,…